28.07.2011 • News

Ashland Q3 Profit Plunges On Raw Material Costs

Ashland Chairman and Chief Executive Officer James OBrien said: Our June...
Ashland Chairman and Chief Executive Officer James O'Brien said: "Our June quarter results were significantly affected by steep raw-material cost increases."

Specialty chemicals company Ashland reported Thursday its third-quarter preliminary results with net income of $87 million or $1.09 per share, lower than last year's $1.85 per share. Income from continuing operations was $69 million or $0.86 per share, compared to last year's $1.46 per share.
Adjusted earnings from continuing operations fell to $0.92 per share from $1.01 per share a year ago.

On average, nine analysts polled by Thomson Reuters expected earnings of $0.84 per share. Analysts' estimates typically exclude special items.
Ashland Chairman and Chief Executive Officer James O'Brien said, "Our June quarter results were significantly affected by steep raw-material cost increases."

However, sales increased 13% to $1.67 billion. Analysts expected sales of $1.65 billion.

Looking ahead, the company noted that its principal challenge in the near term continues to be recovery of raw-material cost increases.

 

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read